These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

649 related articles for article (PubMed ID: 1377411)

  • 1. Valproic acid-induced spina bifida: a mouse model.
    Ehlers K; Stürje H; Merker HJ; Nau H
    Teratology; 1992 Feb; 45(2):145-54. PubMed ID: 1377411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spina bifida aperta induced by valproic acid and by all-trans-retinoic acid in the mouse: distinct differences in morphology and periods of sensitivity.
    Ehlers K; Stürje H; Merker HJ; Nau H
    Teratology; 1992 Aug; 46(2):117-30. PubMed ID: 1440416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exencephaly and axial skeletal malformations induced by maternal administration of sodium valproate in the MF1 mouse.
    Padmanabhan R; Hameed MS
    J Craniofac Genet Dev Biol; 1994; 14(3):192-205. PubMed ID: 7852547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The valproic acid metabolite E-2-n-propyl-2-pentenoic acid does not induce spina bifida in the mouse.
    Ehlers K; Stürje H; Merker HJ; Nau H
    Dev Pharmacol Ther; 1992; 19(4):196-204. PubMed ID: 1343622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The risk of spina bifida aperta after first-trimester exposure to valproate in a prenatal cohort.
    Omtzigt JG; Los FJ; Grobbee DE; Pijpers L; Jahoda MG; Brandenburg H; Stewart PA; Gaillard HL; Sachs ES; Wladimiroff JW
    Neurology; 1992 Apr; 42(4 Suppl 5):119-25. PubMed ID: 1574165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Valproic acid sodium-induced spina bifida occulta in the rat.
    Ceylan S; Duru S; Ceylan S
    Neurosurg Rev; 2001 Mar; 24(1):31-4. PubMed ID: 11339465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New animal model for the study of neural tube defects.
    Michejda M; McCollough D
    Z Kinderchir; 1987 Dec; 42 Suppl 1():32-5. PubMed ID: 3124366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methionine reduces the valproic acid-induced spina bifida rate in mice without altering valproic acid kinetics.
    Ehlers K; Elmazar MM; Nau H
    J Nutr; 1996 Jan; 126(1):67-75. PubMed ID: 8558327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Valproic acid-induced neural tube defects in mouse and human: aspects of chirality, alternative drug development, pharmacokinetics and possible mechanisms.
    Nau H; Hauck RS; Ehlers K
    Pharmacol Toxicol; 1991 Nov; 69(5):310-21. PubMed ID: 1803343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of the skeleton in normal rats and in rats with trypan blue induced spina bifida.
    Peters PW; Verhoef A; De Liefde A; Berkvens JM
    Acta Morphol Neerl Scand; 1981 Mar; 19(1):21-34. PubMed ID: 7020357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative study of the effects of retinoic acid given during the critical period for inducing spina bifida in mice and hamsters.
    Tibbles L; Wiley MJ
    Teratology; 1988 Feb; 37(2):113-25. PubMed ID: 3281303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene-teratogen interaction and its morphological basis in retinoic acid-induced mouse spina bifida.
    Kapron-Brás CM; Trasler DG
    Teratology; 1984 Aug; 30(1):143-50. PubMed ID: 6385329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discontinuity of primary and secondary neural tube in spina bifida induced by retinoic acid in mice.
    Yasuda Y; Konishi H; Kihara T; Tanimura T
    Teratology; 1990 Mar; 41(3):257-74. PubMed ID: 2183387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative analysis of motor neurons of the levator ani muscle in fetal rats with spina bifida occulta.
    Li Y; Hou XY; Yuan ZW; Wang WL
    Surg Neurol; 2009 Dec; 72(6):652-6; discussion 656. PubMed ID: 19328533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amidic modification of valproic acid reduces skeletal teratogenicity in mice.
    Okada A; Kurihara H; Aoki Y; Bialer M; Fujiwara M
    Birth Defects Res B Dev Reprod Toxicol; 2004 Feb; 71(1):47-53. PubMed ID: 14991910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A mouse model for neural tube defects: the curtailed (Tc) mutation produces spina bifida occulta in Tc/+ animals and spina bifida with meningomyelocele in Tc/t.
    Park CH; Pruitt JH; Bennett D
    Teratology; 1989 Mar; 39(3):303-12. PubMed ID: 2658196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Teratogenic effects of sodium valproate in mice and rats at midgestation and at term.
    Menegola E; Broccia ML; Nau H; Prati M; Ricolfi R; Giavini E
    Teratog Carcinog Mutagen; 1996; 16(2):97-108. PubMed ID: 8875740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of supplemental folic acid on valproic acid-induced embryotoxicity and tissue zinc levels in vivo.
    Hansen DK; Grafton TF; Dial SL; Gehring TA; Siitonen PH
    Teratology; 1995 Nov; 52(5):277-85. PubMed ID: 8838251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Valproic acid in pregnancy: how much are we endangering the embryo and fetus?
    Ornoy A
    Reprod Toxicol; 2009 Jul; 28(1):1-10. PubMed ID: 19490988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pantothenic acid decreases valproic acid-induced neural tube defects in mice (I).
    Sato M; Shirota M; Nagao T
    Teratology; 1995 Sep; 52(3):143-8. PubMed ID: 8638254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.